Do TPO antibodies indicate autoimmune thyroid activity that can drive systemic inflammation even if ESR is normal?

Thyroid peroxidase (TPO) antibodies are established clinical markers for autoimmune thyroid activity, and current research confirms that the resulting inflammatory process can persist systemically even when traditional markers like the erythrocyte sedimentation rate (ESR) appear normal.

Evidence for TPO Antibodies and Thyroid Activity

TPO antibodies (TPOAb) are highly specific indicators of autoimmune thyroid involvement, present in approximately 90–95% of Hashimoto’s thyroiditis cases. They act as strong predictors for future thyroid failure, with a relative risk of 1.99 for developing hypothyroidism.

• Pathophysiological Mechanism: TPOAb are not just markers but active participants in tissue damage. They facilitate antibody-dependent cellular cytotoxicity (ADCC) by binding to the surface of thyroid cells and recruiting effector cells—such as natural killer (NK) cells and monocytes—which induce cell lysis and chronic inflammation.

Systemic Inflammatory Signaling

Autoimmune thyroid conditions like Hashimoto's are characterized by extrathyroidal inflammatory signaling that persists even when patients achieve a euthyroid state (normal TSH/T4).

• Cytokine Profiles: Research indicates elevated levels of pro-inflammatory cytokines, specifically interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), in patients with thyroid autoimmunity. These molecules serve as persistent systemic signals of immune activation.
• Discordance with ESR: Standard clinical markers like ESR often lack the sensitivity to detect this low-grade, autoimmune-driven inflammation. Studies show that high-sensitivity C-reactive protein (hs-CRP) is a much more reliable indicator in these patients, with a sensitivity of 67–73% for assessing inflammatory severity. While hs-CRP remains elevated across subclinical and overt stages of the disease, ESR frequently remains within normal ranges, failing to capture the underlying systemic pathology.

Bottom line

TPO antibodies confirm an autoimmune process that generates persistent systemic inflammation via IL-6 and TNF-α. This low-grade inflammatory state often bypasses detection by the erythrocyte sedimentation rate (ESR), necessitating more sensitive markers like hs-CRP for accurate assessment.